These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70 related articles for article (PubMed ID: 10578305)
1. Enzyme-assisted synthesis of disaccharides to inhibit binding of human anti-alpha Gal antibody. Haga I; Satake M; Ohrui H; Ohkohchi N; Satomi S Transplant Proc; 1999 Nov; 31(7):2826-30. PubMed ID: 10578305 [No Abstract] [Full Text] [Related]
2. The footprint of antibody bound to pig cells: evidence of complex surface topology. Everett ML; Lin SS; Worrell SS; Platt JL; Parker W Biochem Biophys Res Commun; 2003 Feb; 301(3):751-7. PubMed ID: 12565844 [TBL] [Abstract][Full Text] [Related]
3. Analysis of the control of the anti-gal immune response in a non-human primate by galactose alpha1-3 galactose trisaccharide-polyethylene glycol conjugate. Diamond LE; Byrne GW; Schwarz A; Davis TA; Adams DH; Logan JS Transplantation; 2002 Jun; 73(11):1780-7. PubMed ID: 12085001 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition by alpha-D-galactose of heterophilic antibodies against the antigens of the interstitial connective tissue of the myocardium]. Danilova TA Biull Eksp Biol Med; 1986 May; 101(5):596-8. PubMed ID: 2423154 [TBL] [Abstract][Full Text] [Related]
5. Characteristics of immunoglobulin gene usage of the xenoantibody binding to gal-alpha(1,3)gal target antigens in the gal knockout mouse. Nozawa S; Xing PX; Wu GD; Gochi E; Kearns-Jonker M; Swensson J; Starnes VA; Sandrin MS; McKenzie IF; Cramer DV Transplantation; 2001 Jul; 72(1):147-55. PubMed ID: 11468550 [TBL] [Abstract][Full Text] [Related]
6. Identification of porcine endothelial cell membrane antigens recognized by human xenoreactive natural antibodies. Holzknecht ZE; Platt JL J Immunol; 1995 May; 154(9):4565-75. PubMed ID: 7722310 [TBL] [Abstract][Full Text] [Related]
7. Removal of anti-Gal alpha (1,3)Gal antibodies diminishes the cytotoxic effect of primate xenoreactive antibodies on rat endothelial cells. Azimzadeh A; Anegon I; Thibaudeau K; Charreau B; Zibolt P; Cinqualbre J; Soulillou JP; Wolf P Transplant Proc; 1997 Aug; 29(5):2337. PubMed ID: 9270751 [No Abstract] [Full Text] [Related]
10. Synthesis of 4-O-glycosylated 1-deoxynojirimycin derivatives as disaccharide mimics-based inhibitors of human beta-glucocerebrosidase. Boucheron C; Toumieux S; Compain P; Martin OR; Ikeda K; Asano N Carbohydr Res; 2007 Sep; 342(12-13):1960-5. PubMed ID: 17407774 [TBL] [Abstract][Full Text] [Related]
11. Variation in expression of biologically reactive xenoantigen does not correlate with expression of Gal alpha (1-3)Gal. Alvarado CG; Cotterell AH; Parker W; Logan JS; Platt JL Transplant Proc; 1996 Apr; 28(2):555. PubMed ID: 8623266 [No Abstract] [Full Text] [Related]
12. Efficiency of different synthetic oligosaccharides for blocking the natural anti-g Gal antibodies found in human and baboon sera. Oriol R; Neethling F; Joziasse D; Bovin N; Cooper DK Transplant Proc; 1996 Apr; 28(2):562. PubMed ID: 8623272 [No Abstract] [Full Text] [Related]
13. Naturally occurring human "antigalactosyl" IgG antibodies are heterophile antibodies recognizing blood-group-related substances. Kay MM; Bosman GJ Exp Hematol; 1985 Dec; 13(11):1103-12. PubMed ID: 3840744 [TBL] [Abstract][Full Text] [Related]
14. Human xenoreactive natural antibodies against Gal alpha (1-3) pig terminal residues are not produced by CD5+ B-lymphocytes. Pitre J; Möller E; Satake M Transplant Proc; 1996 Apr; 28(2):545. PubMed ID: 8623257 [No Abstract] [Full Text] [Related]
15. Carbohydrate residues downstream of the terminal Galalpha(1,3)Gal epitope modulate the specificity of xenoreactive antibodies. Milland J; Yuriev E; Xing PX; McKenzie IF; Ramsland PA; Sandrin MS Immunol Cell Biol; 2007; 85(8):623-32. PubMed ID: 17724458 [TBL] [Abstract][Full Text] [Related]
16. Enzymatic removal from various tissues of the galactose alpha 1,3-galactose target antigens of human antispecies antibodies. Cairns T; Hammelmann W; Gray D; Welsh K; Larson G Transplant Proc; 1994 Jun; 26(3):1279-80. PubMed ID: 7518125 [No Abstract] [Full Text] [Related]
18. Characterization of natural human anti-non-gal antibodies and their effect on activation of porcine gal-deficient endothelial cells. Saethre M; Baumann BC; Fung M; Seebach JD; Mollnes TE Transplantation; 2007 Jul; 84(2):244-50. PubMed ID: 17667817 [TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibody LU-BCRU-G7 against a breast tumour-associated glycoprotein recognizes the disaccharide Gal beta 1-3GlcNAc. Rye PD; Bovin NV; Vlasova EV; Walker RA Glycobiology; 1995 Jun; 5(4):385-9. PubMed ID: 7579792 [TBL] [Abstract][Full Text] [Related]
20. Soluble Galalpha(1,3)Gal conjugate combined with hDAF preserves morphology and improves function of cardiac xenografts. Brandl U; Erhardt M; Michel S; Jöckle H; Burdorf L; Bittmann I; Rössle M; Mordstein V; Brenner P; Hammer C; Reichart B; Schmoeckel M Xenotransplantation; 2007 Jul; 14(4):323-32. PubMed ID: 17669174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]